Press Releases: Page 2
Post a press release | Manage press releases
-
Cycle Pharmaceuticals Selects LeMed Specialty Pharmacy as Exclusive U.S. Specialty Pharmacy Distribution and Services Partner for HARLIKU™ (nitisinone) Tablets
Press release from LeMed Specialty Pharmacy • July 21, 2025 -
Uniphar Rebrands On Demand Business to Uniphar Global Sourcing, Strengthening Global Pharmaceutical Offering
Press release from Uniphar • July 17, 2025 -
Trialt Names Dr. Yuri Kartashov as Chief R&D Officer to Reinforce Strong Biostatistics and Clinical Data Leadership at the Global CRO
Press release from Trialt • July 15, 2025 -
4B Technologies Announces Phase 1 Trial Results for 4B03-04, a Potential First-in-Class Non-Opioid Therapy for Chronic Pain
Press release from 4B Technologies • July 13, 2025 -
Woven Health Collective Acquires Boundless Life Sciences Group to Expand Digital and Creative Marketing Capabilities
Press release from Woven Health Collective • July 9, 2025 -
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review
Press release from ProPharma • July 8, 2025 -
Not Just a Patch earns FDA, EU clearance for CGM patches line, expanding diabetes support offerings
Press release from Not Just a Patch • July 4, 2025 -
Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001
Press release from Neurizon Therapeutics • July 3, 2025 -
Nobel Laureate Morten Meldal Joins Receptor.AI as Scientific Advisor
Press release from Receptor.AI • July 2, 2025 -
Lutroo Imaging Begins Phase 1 Clinical Trial of Radiocaine™, a First-in-Class PET Radiotracer for Pain Imaging and Diagnosis
Press release from Lutroo Imaging • July 1, 2025 -
Noah AI Launches Specialized AI Agent to Empower Biomedical Professionals with Intelligent Insights
Press release from Noah AI • June 30, 2025 -
Transcenta Strengthens Osemitamab Promise for G/GEJ Cancer with OS Data from First-Line Triple Combo Trial
Press release from Transcenta • June 25, 2025 -
Vial Announces Dosing of First Participants in Phase 1 Healthy Volunteer Trial of a Novel Subcutaneous Half-Life Extended Anti-TL1A Antibody
Press release from Vial • June 25, 2025 -
START Launches Hope Hub to Connect Patients, Physicians, and Advocacy Groups to Community-Based Cancer Trials
Press release from The START Center for Cancer Research • June 24, 2025 -
Sciwind Biosciences Announces Publication of Phase III SLIMMER Trial Results in The Lancet Diabetes & Endocrinology and Oral Presentation at ADA Scientific Sessions
Press release from Sciwind Biosciences • June 21, 2025 -
MMS Wins in the 2025 Fierce CRO Awards for Excellence in Client Service and Partnership and its CEO Named CRO Champion
Press release from MMS • June 19, 2025 -
TrialAssure Enhances REGISTRY Platform with AI-Powered Protocol Parsing to Streamline Global Clinical Trial Registration
Press release from TrialAssure • June 17, 2025 -
BeWell Family Care and Axsendo Clinical Research Announce Strategic Clinical Research Partnership in Phoenix, Arizona
Press release from Axsendo Clinical Research • June 16, 2025 -
Ann Arbor-based Life Science Companies TSRL, AnchorBio, and AAPharmaSyn Launch The A2 BioPharm Collaborative at BIO 2025
Press release from TSRL, Inc. • June 16, 2025 -
Cliniphai Unveils Marketplace Model for Athena Clinical Translation and Localization Platform at BIO 2025 in Boston
Press release from Cliniphai • June 16, 2025
Previous
